About one in nine adults suffer from chronic insomnia and its residual effects like drowsiness, cognitive issues, and ...

SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of ...

The Calderwood Inn, on Maxwellton Avenue, is described as having "plenty of character" and could be yours for an annual rent ...

Amazon’s acquisition of Bee highlights a shift in how the company views AI assistants. Rather than focusing only on smart ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

It's been a long time coming: Four years after Omeros came up short in its bid to gain an FDA approval for stem cell transplant drug narsoplimab, the Seattle biotech has finally scored its ...

Omeros has won U.S. Food and Drug Administration approval of its Yartemlea treatment for an often-fatal complication of stem-cell transplants. Omeros on Wednesday said the approval covers Yartemlea ...

Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA ® (narsoplimab-wuug) for the treatment of hematopoietic stem cell ...

Supplements that can help you stay physically and mentally healthy during the winter include vitamin D, zinc, vitamin C, and ...

Companies that are successfully using AI tools and services get the most from the technology by embracing and integrating it ...